Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. OSCR
OSCR logo

OSCR Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
28.850
Open
28.570
VWAP
28.27
Vol
6.78M
Mkt Cap
8.56B
Low
27.570
Amount
191.73M
EV/EBITDA(TTM)
102.52
Total Shares
301.49M
EV
4.19B
EV/OCF(TTM)
1.48
P/S(TTM)
0.60
Oscar Health, Inc. is a healthcare technology company built around a full stack technology platform. The Company's offerings include its insurance business and +Oscar Platform. Its health plans are offered in the individual market. The individual market primarily consists of policies purchased by individuals and families through health insurance marketplaces, established by the ACA and operated by the federal government, as well as other marketplaces operated by individual states. Individuals and families may also purchase policies in the individual market off-exchange. Employees whose employers have chosen to offer an Individual Coverage Health Reimbursement Arrangement (ICHRA) are also able to purchase its health plans. It offers health plans in the individual market under the five metal plan categories defined by the ACA: Catastrophic, Bronze, Silver, Gold, and Platinum. Through the +Oscar platform, the Company deploys its technology to help others throughout the healthcare system.
Show More

Events Timeline

(ET)
2026-06-10
16:30:00
US Stocks Drop Sharply Amid Renewed US-Iran Tensions
select
2026-06-10
12:10:00
Major U.S. Averages Decline Amid Escalating Geopolitical Tensions
select
2026-06-04 (ET)
2026-06-04
16:40:00
Dow Jones Rises 1.73%, Nasdaq Declines
select
2026-06-04
12:10:00
Dow Jones Up 800 Points, Nasdaq Slips
select
2026-06-04
12:10:00
Oscar Health Shares Rise 15% to $23.58
select
2026-06-04
10:10:00
Oscar Health Shares Rise 12.1% to $22.99
select

News

Fool
8.5
06-14Fool
Oscar Health: Disruptor in the Health Insurance Market
  • Massive Market Potential: The U.S. healthcare industry spends trillions annually, with growth expected to outpace inflation due to an aging population, presenting significant opportunities for innovative companies like Oscar Health.
  • Customer Base Expansion: Oscar Health has grown its customer count to 3.2 million over the past few years, establishing itself as a major player in the ACA marketplace, demonstrating its ability to stand out among traditional insurers with substantial growth potential ahead.
  • Record Revenue Guidance: Oscar Health anticipates reaching $19 billion in revenue and $450 million in operating income by 2026, both record figures for the company, indicating its success in leveraging network effects and customer growth.
  • Significant Profit Potential: If Oscar Health doubles its customer base to 6.5 million over the next five years, its 2026 premium revenue could reach $50 billion, with a 5% operating margin translating to $2.5 billion in annual operating income, highlighting the investment value of its stock.
NASDAQ.COM
9.5
06-14NASDAQ.COM
Oscar Health's Massive Profit Potential by 2026
  • Market Share Growth: Oscar Health has reached 3.2 million customers this year, establishing itself as a major player in the ACA marketplace, indicating a competitive edge over traditional health insurers and expected continued market share expansion.
  • Revenue Guidance Innovation: The company anticipates reaching $19 billion in revenue and $450 million in operating income by 2026, both record highs, indicating a significant improvement in profitability within the health insurance sector.
  • Enhanced Customer Experience: By offering free telehealth services and dedicated online customer support, Oscar Health has achieved customer satisfaction levels significantly higher than traditional insurers, which is expected to attract new clients and enhance customer loyalty.
  • Long-Term Growth Potential: If the customer base doubles to 6.5 million over the next five years, premium revenue could reach $50 billion by 2026, potentially generating $2.5 billion in annual operating income at a 5% margin, highlighting the investment value of its stock.
stocktwits
8.5
06-11stocktwits
Applied Materials Opens $500M Singapore Campus, Hits 52-Week High
  • Manufacturing Expansion: Applied Materials opened its $500 million Tampines Campus in Singapore, leading its stock to reach a 52-week high of $534.44 on Wednesday, with the new facility more than doubling cleanroom space and helping semiconductor manufacturers meet the growing demand from AI-related technologies, thereby enhancing the company's future growth potential.
  • Telecom Technology Milestone: AmpliTech shares climbed to a five-year high of $8.29 after successfully participating in the O-RAN ALLIANCE Global PlugFest, where its advanced radio technology demonstrated interoperability with major telecommunications operators' equipment, marking a significant step toward broader commercial adoption of its 5G infrastructure products and strengthening its position within the Open RAN ecosystem.
  • Analyst Rating Upgrade: Oscar Health received support from Barclays analyst Andrew Mok, who upgraded the stock from 'Equal Weight' to 'Overweight' and raised the price target from $30 to $35, noting that Oscar provides investors with a direct way to benefit from growth in the Affordable Care Act insurance market, with greater gains expected if demand for ACA plans continues to rise.
  • Strong Market Performance: Despite a broader market pause, shares of Applied Materials, AmpliTech, and Oscar Health all reached new 52-week highs on Wednesday, with AMAT and OSCR stocks surging 93% year-to-date, while AMPG stock jumped over 154%, reflecting strong investor confidence in the future growth of these companies.
CNBC
2.0
06-10CNBC
Amazon's Logistics Expansion Hits Freight Stocks Hard
  • Freight Stocks Decline: Amazon's announcement to open its less-than-truckload shipping services to external companies led to a 5% drop in FedEx Freight and Old Dominion Freight Line, and a 4% decline in XPO, indicating a significant threat to industry incumbents and potential market share erosion.
  • Super Micro Stock Plunge: Super Micro Computer's plan to raise $7 billion through equity and equity-linked securities to cover hardware component costs resulted in an 18% stock drop, reflecting market concerns over its financing strategy and potential long-term implications for growth.
  • Energy Stocks Rally: Devon Energy's stock surged over 6% after Evercore ISI upgraded its rating to outperform, following a better-than-expected mid-month update post the $58 billion acquisition of Coterra Energy, showcasing strong performance in the oil and gas sector.
  • Restaurant Stocks Surge: Cracker Barrel's stock soared 24% after raising its full-year revenue and adjusted EBITDA guidance, reporting fiscal Q3 earnings of $0.29 per share on $797.4 million in revenue, exceeding analyst expectations and indicating robust business recovery.
CNBC
6.0
06-10CNBC
Latest Wall Street Ratings Overview
  • Tesla's Self-Driving Tech: Piper Sandler reiterates Tesla as overweight, highlighting progress in its full self-driving software despite ongoing market skepticism, reflecting competitive pressures in the autonomous driving sector.
  • Hyliion Stock Rating: Needham initiates coverage of Hyliion Holdings with a Buy rating and a $9 target, indicating strong performance in power solutions and showcasing the company's market potential and growth momentum.
  • Healthcare Market Opportunity: Barclays upgrades Oscar Health from equal weight to overweight, believing the company's single-line exposure to the Individual ACA market provides direct leverage for potential multi-year re-rating, signaling recovery in margins.
  • Nvidia Stock Attractiveness: Rosenblatt reiterates Nvidia as a Buy, emphasizing its leadership in AI computing and strong growth visibility, with shares currently trading at a ~35% discount to peers, indicating significant investment value.
NASDAQ.COM
8.5
06-09NASDAQ.COM
Tango Therapeutics Shares Surge Over 50% on Positive Trial Data
  • Positive Clinical Trial Data: Tango Therapeutics' Vopimetostat shows a 90% six-month progression-free survival rate in its Phase 1/2 trial for pancreatic cancer, prompting plans to advance to Phase 3, thereby enhancing its competitive edge in cancer treatment.
  • Aspire Biopharma Growth Prospects: Aspire Biopharma aims to file its NDA for high-dose sublingual aspirin by the end of 2026, and its acquisition of Dura Driver Control Systems is expected to generate over $200 million in revenue, further solidifying its market position.
  • Alvotech FDA Application Progress: Alvotech's AVT16 biosimilar application has been accepted for FDA review, which is anticipated to significantly bolster its competitive stance in the biopharmaceutical market, particularly for treating Crohn's disease and ulcerative colitis.
  • Zevra Patent Protection Enhancement: Zevra Therapeutics' MIPLYFFA has been listed in the Orange Book by the U.S. Patent Office, with patent protection extending to 2041, expected to significantly enhance its exclusivity and revenue potential in the rare disease market.
Wall Street analysts forecast OSCR stock price to rise
8 Analyst Rating
Wall Street analysts forecast OSCR stock price to rise
1 Buy
4 Hold
3 Sell
Hold
Current: 0.000
sliders
Low
11.00
Averages
15.75
High
25.00
Current: 0.000
sliders
Low
11.00
Averages
15.75
High
25.00
Wells Fargo
upgrade
$20.81
AI Analysis
2026-06-04
Reason
Wells Fargo
Price Target
$20.81
AI Analysis
2026-06-04
upgrade
Reason
Oscar Health up 2% to $20.81 after Wells Fargo upgrade
Wells Fargo
Stephen Baxter
Underweight
to
Equal Weight
upgrade
$11 -> $20
2026-06-04
Reason
Wells Fargo
Stephen Baxter
Price Target
$11 -> $20
2026-06-04
upgrade
Underweight
to
Equal Weight
Reason
Wells Fargo analyst Stephen Baxter upgraded Oscar Health to Equal Weight from Underweight with a price target of $20, up from $11. The firm cites greater confidence in the company's 2026 exchange market trajectory for the upgrade. Wells is now "increasingly comfortable" with the trajectory of the exchange market in 2026. However, Oscar's visibility beyond this year remains low, the analyst tells investors in a research note. Wells says the company's payment integrity will remain an investor focus.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for OSCR
Unlock Now

Valuation Metrics

The current forward P/E ratio for Oscar Health Inc (OSCR.N) is 588.24, compared to its 5-year average forward P/E of 84.91. For a more detailed relative valuation and DCF analysis to assess Oscar Health Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
84.91
Current PE
588.24
Overvalued PE
276.12
Undervalued PE
-106.29

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-27.07
Current EV/EBITDA
1.38
Overvalued EV/EBITDA
113.12
Undervalued EV/EBITDA
-167.25

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.38
Current PS
0.43
Overvalued PS
0.68
Undervalued PS
0.08

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

stocks that breakout today
Intellectia · 13 candidates
Market Cap: >= 1000.00MPrice: >= $10.00Price Change Pct: >= $5.00Relative Vol: >= 2Support Resistance Relationship: PriceBreakResistance
Ticker
Name
Market Cap$
top bottom
AEHR logo
AEHR
Aehr Test Systems
1.96B
OSCR logo
OSCR
Oscar Health Inc
4.36B
RPM logo
RPM
RPM International Inc
13.90B
SIM logo
SIM
Grupo Simec SAB de CV
5.27B
FUTU logo
FUTU
Futu Holdings Ltd
21.88B
NESR logo
NESR
National Energy Services Reunited Corp
2.42B
mid-cap stocks about to break bullish
Intellectia · 61 candidates
Market Cap: 2.00B - 10.00BRsi Category: moderateList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Week Price Change Pct: >= $5.00Support Resistance Relationship: PriceBreakResistance
Ticker
Name
Market Cap$
top bottom
PLUG logo
PLUG
Plug Power Inc
3.11B
INTA logo
INTA
Intapp Inc
2.10B
BWIN logo
BWIN
Baldwin Insurance Group Inc
3.18B
WIX logo
WIX
Wix.Com Ltd
4.60B
SM logo
SM
SM Energy Co
5.74B
RCUS logo
RCUS
Arcus Biosciences Inc
2.81B
what are some day trades i can do with 300$
Intellectia · 122 candidates
Region: USPrice: $1.00 - $30.00Price Change Pct: $3.00 - $100.00Relative Vol: >= 1.50Beta: HighRiskList Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
UWMC logo
UWMC
UWM Holdings Corp
6.66B
PATH logo
PATH
UiPath Inc
5.32B
AAL logo
AAL
American Airlines Group Inc
8.80B
OPEN logo
OPEN
Opendoor Technologies Inc
4.77B
RGTI logo
RGTI
Rigetti Computing Inc
5.82B
LUNR logo
LUNR
Intuitive Machines Inc
3.23B
which stock will moon this year?
Intellectia · 722 candidates
Market Cap: >= 1000.00MQuarter Revenue Yoy Growth: >= 0.0%Revenue 5yr Cagr: >= 5List Exchange: XNYS, XNAS, XASEYtd Price Change Pct: >= $0.00
Ticker
Name
Market Cap$
top bottom
TGTX logo
TGTX
TG Therapeutics Inc
5.02B
MARA logo
MARA
MARA Holdings Inc
3.89B
IREN logo
IREN
IREN Ltd
17.19B
LCID logo
LCID
Lucid Group Inc
3.72B
SMR logo
SMR
Nuscale Power Corp
6.25B
CLSK logo
CLSK
CleanSpark Inc
3.37B
best stocks for November
Intellectia · 19 candidates
Beta: ModerateRisk, HighRiskWeekly Average Turnover: >= 20,000,000Pe Ttm: <= 15Month Price Change Pct: >= $0.00Annual Eps Yoy Growth: >= 40.0%Annual Revenue Yoy Growth: >= 40.0%
Ticker
Name
Market Cap$
top bottom
IBRX logo
IBRX
Immunitybio Inc
6.82B
UAMY logo
UAMY
United States Antimony Corp
1.28B
BKKT logo
BKKT
Bakkt Holdings Inc
533.40M
ARDX logo
ARDX
Ardelyx Inc
1.94B
GROY logo
GROY
Gold Royalty Corp
1.10B
TWO logo
TWO
Two Harbors Investment Corp
1.40B

Whales Holding OSCR

B
BIT Capital GmbH
Holding
OSCR
+32.68%
3M Return
S
Sessa Capital IM, L.P.
Holding
OSCR
+20.56%
3M Return
D
Dragoneer Investment Group, LLC
Holding
OSCR
+6.02%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Oscar Health Inc (OSCR) stock price today?

The current price of OSCR is 28.4 USD — it has increased 0.46

What is Oscar Health Inc (OSCR)'s business?

Oscar Health, Inc. is a healthcare technology company built around a full stack technology platform. The Company's offerings include its insurance business and +Oscar Platform. Its health plans are offered in the individual market. The individual market primarily consists of policies purchased by individuals and families through health insurance marketplaces, established by the ACA and operated by the federal government, as well as other marketplaces operated by individual states. Individuals and families may also purchase policies in the individual market off-exchange. Employees whose employers have chosen to offer an Individual Coverage Health Reimbursement Arrangement (ICHRA) are also able to purchase its health plans. It offers health plans in the individual market under the five metal plan categories defined by the ACA: Catastrophic, Bronze, Silver, Gold, and Platinum. Through the +Oscar platform, the Company deploys its technology to help others throughout the healthcare system.

What is the price predicton of OSCR Stock?

Wall Street analysts forecast OSCR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OSCR is15.75 USD with a low forecast of 11.00 USD and a high forecast of 25.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Oscar Health Inc (OSCR)'s revenue for the last quarter?

Oscar Health Inc revenue for the last quarter amounts to 4.65B USD, increased 52.55

What is Oscar Health Inc (OSCR)'s earnings per share (EPS) for the last quarter?

Oscar Health Inc. EPS for the last quarter amounts to 2.06 USD, increased 128.89

How many employees does Oscar Health Inc (OSCR). have?

Oscar Health Inc (OSCR) has 2305 emplpoyees as of June 20 2026.

What is Oscar Health Inc (OSCR) market cap?

Today OSCR has the market capitalization of 8.56B USD.